Markets
Thursday, September 24, 2026
The Company Chronicle

NYSE · traded in Congress

Boston Scientific BSX

$43.34 -0.21 (-0.48%) Sep 17, 2026

Market value$62.8B
P/E ratio-
Analyst target$57.00
52-week range-
Avg volume8,684,835
Dividend yield-

Chart

Congress trades in BSX

Members of Congress disclosed 8 transactions in BSX in the filings we have processed.

TradedMemberTypeAmountFiled
08/18/2026 Gilbert Cisneros CA31 Purchase $1,001 - $15,000 9/10/2026 filing
06/05/2026 Gilbert Cisneros CA31 Purchase $1,001 - $15,000 7/2/2026 filing
06/05/2026 Gilbert Cisneros CA31 Partial sale $1,001 - $15,000 7/2/2026 filing
05/29/2026 Gilbert Cisneros CA31 Purchase $1,001 - $15,000 6/8/2026 filing
05/19/2026 Gilbert Cisneros CA31 Purchase $1,001 - $15,000 6/8/2026 filing
05/11/2026 Gilbert Cisneros CA31 Purchase $1,001 - $15,000 6/8/2026 filing
02/10/2026 Gilbert Cisneros CA31 Purchase $1,001 - $15,000 3/9/2026 filing
01/30/2026 Gilbert Cisneros CA31 Purchase $1,001 - $15,000 2/13/2026 filing

Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›

Other companies

Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView. Congressional trades parsed from official House filings. Market information, not investment advice.